Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Peter Stein Takes Short Path To Director Of US FDA Drug Office

Dec 10 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

New CDER No. 2 May Impact FDA's Safety Monitoring Aspirations

Apr 18 2018

Gottlieb: The Next Janet Woodcock Is Waiting To Be Discovered At FDA

Nov 09 2017

'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs

Dec 05 2016

Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director

Nov 09 2016

Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

Jun 04 2018

CDER Recruitment Wins Begin Outnumbering Losses

Nov 27 2018

US FDA Office Of New Drugs Likely To Be Headed By Deputy Director Stein

Nov 21 2018

Related Companies

Merck & Co., Inc.

Johnson & Johnson

Pfizer Inc.

Additional Topics

United States FDA Drug Review Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window